Clinical significance of plasma D-dimer level in therapeutic evaluation of patients with malignant lymphoma
10.3760/cma.j.issn.1009-9921.2014.06.007
- VernacularTitle:血浆D-二聚体在恶性淋巴瘤患者疗效评价中的价值
- Author:
Junli CAO
;
Huaqing WANG
;
Zhengzi QIAN
;
Huilai ZHANG
;
Zheng SONG
;
Xianhuo WANG
- Publication Type:Journal Article
- Keywords:
Lymphoma;
D-dimer;
Treatment outcome
- From:
Journal of Leukemia & Lymphoma
2014;23(6):347-349,357
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical significance of plasma D-dimer level before and after chemotherapy in patients with malignant lymphoma.Methods 402 patients admitted to Tianjin Medical University Cancer Institute and Hospital and pathologically diagnosed with malignant lymphoma were retrospectively analyzed to investigate the relationship between patients' plasma D-dimer level and their clinic pathology.Meanwhile,the association between patients' plasma D-dimer level change after chemotherapy and therapeutic effect was also evaluated.Results The median plasma D-dimer levels in malignant lymphoma patients (734.51ng/ml) was distinctly higher than that in normal population (＜500 ng/ml).The plasma D-dimer level had obvious correlation with age,pathological type,level of LDH,clinical stage,B symptom and IPI score.The level of plasma D-dimer in positive response group significantly decreased from 949.40 ng/ml to 499.88 ng/ml after chemotherapy (P ＜ 0.05),whereas that in the negtive response group significantly increased from 611.09 ng/ml to 899.76 ng/ml (P ＜ 0.05).Conclusion The level of plasma D-dimer may provide the basis for evaluating the chemotherapeutic effect in patients with malignant lymphoma.
